|

Pantoprazole in Cisplatin Nephrotoxicity

RECRUITINGPhase 3Sponsored by Sherief Abd-Elsalam
Actively Recruiting
PhasePhase 3
SponsorSherief Abd-Elsalam
Started2019-05-01
Est. completion2030-12-01
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04217512

Summary

Pantoprazole in Cisplatin Nephrotoxicity

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients with head and neck cancer

Exclusion Criteria:

* GFR less than 59.
* DM
* Elevated liver enzymes more than 3 fold.

Conditions2

CancerOncology

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.